Scientist Radiochemistr
Denne stilling er desværre ikke længere ledig.
Se alle ledige stillinger
Scientist RadiochemistrY
Exciting opportunitY to become part of Y-mAbs’ valuable work and companY, and to contribute to the fight against cancer
As Scientist RadiochemistrY at Y-mAbs, You will join the CMC development team, and therebY become an integrated part of the ongoing development activities in the field of radiochemistrY. You will work with some of the most talented and experienced professionals in the antibodY industrY.
With direct report to Senior Director, CMC Development, Tore Søderblom, and collaboration with Y-mAbs’ own functions as well as relevant CMO partners.
Your main tasks are:
Your qualifications are a minimum of 2 Years’ experience gained from the pharmaceutical industrY, or as a postdoc student with experience from relevant, pharmaceutical companies. You possess great knowledge in the fields of radiochemistrY/chemistrY/nuclear chemistrY, and a solid understanding of the research and development within. It is crucial that You possess up to date knowledge on regulatorY requirements for both CMC development and GMP regulations.
You have a relevant degree within the industrY og ChemistrY, alternativelY from relevant, scientific fields (oncologY, cancer, immunologY etc.).
You are a person with a proactive and ambitious mindset, and You hold great integritY in Your worktasks and approaches. You manage to familiarize Yourself throughlY in the market and products, and are a great collaborator and have great analYtical skills.
Working in a growing biotech companY, that focusses on cancer in different stages, bY antibodY immunotherapY treatment, You will have a high degree of influence on the job, and You will be able to make a valuable footprint in the fight against cancer that affects millions of people.
Travelling: AbilitY to flY to various international meetings, conferences, or sites, including overnight trips.
Domicile: Driving distance to Hørsholm, Denmark, with the possibilitY for working remote, with at least one week pr month at the office in Hørsholm.
For more details about the job or the companY, please contact CEO Jørn Duhn, Unique Human Capital on M: +45 21 75 19 25 or Research Consultant Emma Josephine Dahl, Unique Human Capital on M: +45 51 43 43 17. All applications must be in English and are treated confidentiallY.
Exciting opportunitY to become part of Y-mAbs’ valuable work and companY, and to contribute to the fight against cancer
As Scientist RadiochemistrY at Y-mAbs, You will join the CMC development team, and therebY become an integrated part of the ongoing development activities in the field of radiochemistrY. You will work with some of the most talented and experienced professionals in the antibodY industrY.
With direct report to Senior Director, CMC Development, Tore Søderblom, and collaboration with Y-mAbs’ own functions as well as relevant CMO partners.
Your main tasks are:
- Radiolabeling of earlY-stage lead candidates for Y-mAbs development programs
- Radiolabeling of clinical and potential commercial products for Y-mAbs development programs
- Prepare and maintain overall and detailed project plans and coordinate with internal and external stakeholders
- Give input to the CMC part of regulatorY documentation
- Interaction with regulatorY agencies
- Secure clinical trial material
- Initiation of change controls
- Input in Product QualitY Review/Annual Product Review
- Review of deviations and qualitY investigations from CMOs, CTLs, and transporters
- Participation in product recall activities
Your qualifications are a minimum of 2 Years’ experience gained from the pharmaceutical industrY, or as a postdoc student with experience from relevant, pharmaceutical companies. You possess great knowledge in the fields of radiochemistrY/chemistrY/nuclear chemistrY, and a solid understanding of the research and development within. It is crucial that You possess up to date knowledge on regulatorY requirements for both CMC development and GMP regulations.
You have a relevant degree within the industrY og ChemistrY, alternativelY from relevant, scientific fields (oncologY, cancer, immunologY etc.).
You are a person with a proactive and ambitious mindset, and You hold great integritY in Your worktasks and approaches. You manage to familiarize Yourself throughlY in the market and products, and are a great collaborator and have great analYtical skills.
Working in a growing biotech companY, that focusses on cancer in different stages, bY antibodY immunotherapY treatment, You will have a high degree of influence on the job, and You will be able to make a valuable footprint in the fight against cancer that affects millions of people.
Travelling: AbilitY to flY to various international meetings, conferences, or sites, including overnight trips.
Domicile: Driving distance to Hørsholm, Denmark, with the possibilitY for working remote, with at least one week pr month at the office in Hørsholm.
For more details about the job or the companY, please contact CEO Jørn Duhn, Unique Human Capital on M: +45 21 75 19 25 or Research Consultant Emma Josephine Dahl, Unique Human Capital on M: +45 51 43 43 17. All applications must be in English and are treated confidentiallY.
Information og data
Denne ledige stilling har jobtypen "Forsker", og befinder sig i kategorien "Sundhed og forskning".
Jobbet er oprettet på vores service den 9.8.2022, men kan have været deaktiveret og genaktiveret igen.
Dagligt opdateret: Dette job opdateres dagligt ud fra jobudbyderens hjemmeside via vores søgemaskineteknologi og er aktivt lige nu.
- Forsker
Statistik over udbudte jobs som forskere
Herunder ser du udviklingen i udbudte forsker over tid. Bemærk at jobs der ikke har en bestemt geografi ikke er medtaget i tabellen. I den første kolonne ser du datoen. I den næste kolonne ser du det samlede antal forskere.
Se flere statistikker her:
Statistik over udbudte forskere over tid
Dato | Alle jobs som forskere |
---|---|
22. november 2024 | 381 |
21. november 2024 | 388 |
20. november 2024 | 371 |
19. november 2024 | 336 |
18. november 2024 | 354 |
17. november 2024 | 355 |
16. november 2024 | 356 |
15. november 2024 | 399 |
14. november 2024 | 371 |
13. november 2024 | 388 |
12. november 2024 | 394 |
11. november 2024 | 405 |
10. november 2024 | 404 |
9. november 2024 | 420 |
8. november 2024 | 406 |
7. november 2024 | 404 |
6. november 2024 | 405 |
5. november 2024 | 391 |
4. november 2024 | 387 |
3. november 2024 | 398 |
2. november 2024 | 402 |
1. november 2024 | 425 |
31. oktober 2024 | 439 |
30. oktober 2024 | 433 |
29. oktober 2024 | 433 |
28. oktober 2024 | 438 |
27. oktober 2024 | 473 |
26. oktober 2024 | 477 |
25. oktober 2024 | 399 |
24. oktober 2024 | 446 |
23. oktober 2024 | 468 |